Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)

SHA:688373 Revenue

In the year 2025, Shanghai MicuRx Pharmaceutical had annual revenue of 141.77M CNY with 8.83% growth. Shanghai MicuRx Pharmaceutical had revenue of 37.79M in the quarter ending December 31, 2025, with 15.52% growth.

• Revenue: 141.77M
• Revenue Growth: +8.83%
• P/S Ratio: 28.74
• Revenue / Employee: 754.11K
• Employees: 177
• Market Cap: 4.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	141.77M	11.50M	8.83%
Dec 31, 2024	130.27M	39.50M	43.51%
Dec 31, 2023	90.78M	42.57M	88.31%
Dec 31, 2022	48.21M	40.55M	529.33%
Dec 31, 2021	7.66M	-	-